Roche shares pop 4% on $5.3 billion obesity drug deal with Zealand Pharma
Roche has agreed to a $5.3 billion deal with Zealand Pharma to develop the obesity drug candidate petrelintide, including a ...
Monday, April 14, 2025
Tag: Roche Holding AG
Stay informed with News Wave - your reliable source for breaking news, insightful analysis, and engaging stories all in a summarized format.